Eloxx Pharmaceuticals (ELOX US)

Eloxx Pharmaceuticals, Inc. operates as a clinical-stage biopharmaceutical company. The Company develops molecule medicines to treat rare and ultra-rare genetic diseases caused by non-sense mutations. Eloxx Pharmaceuticals serves patients in the United States and Israel.